DiabeDoc

25/07/2025

Review: 7,000 steps a day enough for health benefits

A review in The Lancet Public Health suggests 7,000 steps daily may suffice for health benefits, challenging the 10,000-step target. The analysis of data for more than 160,000 adults found 7,000 steps reduced risks for death, heart disease and other conditions, with benefits plateauing beyond that.

THURSDAY, July 23, 2025 (HealthDay News) — Walkers don’t need to march 10,000 steps a day to gain substantial health benefits, a comprehensive new evidence revi

25/07/2025

*Non invasive glucometer* on social media marketing:
FACTS

No, there are currently no non-invasive glucometers fully approved by the FDA for use in India or anywhere else. While some non-invasive technologies are in development and undergoing trials, none have achieved the necessary accuracy and safety standards for widespread approval. The FDA has cleared some continuous glucose monitoring (CGM) systems, like the FreeStyle Libre and Dexcom G6, but these still require a sensor to be inserted under the skin, making them minimally invasive rather than fully non-invasive.

25/07/2025

Newer drugs for managing obesity.
Dr. Shashank Joshi, Endocrinologist, Mumbai

Are weight loss drugs the magic pill that people are talking about? Listen to what India’s leading Endocrinologist Padma Shri Dr. Shashank Joshi has to say ...

25/07/2025

What role do GIP/GLP-1 agonists play in weight management with newer drugs?
https://www.medscape.com/infosites/429099.3/isarticle-1?src=0_nl_sm_0&uac=346463FT

24/07/2025

Tirzepatide compared with semaglutide for diabetes care
Injection pens with dosage indicators.

A post hoc analysis of the phase 3 SURPASS-2 trial presented at a meeting of the Endocrine Society found that tirzepatide was more effective than semaglutide in helping patients with type 2 diabetes achieve key therapeutic targets. The study, involving 1,879 patients, showed tirzepatide led to better control of standard targets such as A1C, blood pressure, LDL cholesterol and weight loss. Full Story: Medscape

Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

28/01/2025

Samsung Non Invasive glucose monitor is game changer for Diabetic patients.

Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung has news.

30/09/2024

World ❤️ day message by Padamshri Professor Dr Shashank Joshi,a renowned endocrinologist from Mumbai.

This World Heart Day, join us for an enlightening conversation as Saffolalife and The Faye D’Souza Show come together to bring you Dr. Shashank R. Joshi, one...

25/02/2024

Drug & Device Trials
US FDA warns against using smartwatches to measure blood glucose
Reuters
February 23, 202412:29 AM GMT+5:30Updated 3 days agoFeb 21 (Reuters) -
The U.S. Food and Drug Administration warned consumers on Wednesday against using smartwatches or smart rings that claim to measure blood glucose levels without piercing the skin, regardless of manufacturer or brand.
The health regulator said it was working to ensure that manufacturers, distributors and sellers do not illegally market unauthorized gadgets that claim to measure blood glucose levels.
The devices are different from smartwatch applications that display data from FDA-authorized blood glucose measuring devices that puncture the skin, the regulator said.
The agency said it had not authorized, cleared, or approved any smartwatch or smart ring intended to measure or estimate blood glucose values on its own, nor evaluated their safety or effectiveness.
Such devices are manufactured by dozens of companies and sold under multiple brand names. Their makers often claim the gadgets can measure blood glucose levels without requiring users to prick their skin.

21/11/2023

Research Society for Study of Diabetes in India (RSSDI) Annual Conference at Jio World Convention Centre, BKC, Mumbai.
Diabetes ka Mahakumbh

16th - 19th Nov,2023

11/07/2023

Non invasive Glucometer GWave will change the life of millions of Diabetic patients.
GWave is the world's first non-invasive glucometer, which offers a disruptive solution utilizing radio frequency (RF) waves to continuously measure glucose levels in the blood.

11/07/2023

Hagar Noninvasive Glucometer
GWave

Hagar Technology is the developer of GWave, the world's first non-invasive continuous glucose monitoring device that utilizes RF waves to measure glucose levels continuously. The GWave sensor is built into a comfortable bracelet the size of a smartwatch that sends glucose readings to the user via a smartphone app that can easily be shared with their healthcare provider

16/05/2023

World Hypertension day 17May